Top compounds associated with response to TEF

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Gemcitabine	gCSI	pan-cancer	AAC	-0.24	7e-06
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.16	9e-06
mRNA	Doxorubicin	gCSI	pan-cancer	AAC	-0.22	2e-05
mRNA	navitoclax:PLX-4032 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.14	0.0001
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.14	0.0001
mRNA	Irinotecan	gCSI	pan-cancer	AAC	-0.2	0.0002
mRNA	Methotrexate	CTRPv2	pan-cancer	AAC	-0.14	0.0002
mRNA	BRD-K45681478	CTRPv2	pan-cancer	AAC	0.14	0.0002
mRNA	UNC0638:navitoclax (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.14	0.0002
mRNA	ABT-263	CTRPv2	pan-cancer	AAC	0.13	0.0003

Download CSV